Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|March 1, 1993
Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomasB K Erikstein, H Holte, S Kvaløy, et al.
European Journal of Immunology|July 1, 1989
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigensH Holte, H K Blomhoff, K Beiske, et al.
Bone Marrow Transplantation|October 12, 1999
High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphomaA Blystad, G Kvalheim, E Torlakovic, et al.
Blood Cancer Journal|July 26, 2012
Entourage: the immune microenvironment following follicular lymphomaB E Wahlin, B Sander, B Christensson, et al.
Experimental Cell Research|July 1, 1987
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytesE B Smeland, H K Blomhoff, H Holte, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1996
[High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood]A Kolstad, H Holte, S Kvaløy, et al.
British Journal of Cancer|July 23, 2009
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal studyT Wethal, M-B Lund, T Edvardsen, et al.
European Journal of Immunology|January 1, 1990
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separationS Funderud, B Erikstein, H C Asheim, et al.
International Journal of Cancer|May 15, 1987
The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomasH Holte, C D Davies, S Kvaløy, et al.
Pageof 10